A Report on the Australian Diabetes Care Devices Market: Discover Investment Opportunities,...
* Reuters is not responsible for the content in this press release.
A Report on the Australian Diabetes Care Devices Market: Discover Investment Opportunities, Market Analysis and Forecasts to 2012 DUBLIN, Ireland--(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/d20521/australia_diabetes) has announced the addition of Global Markets Direct's new report "Australia Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2012" to their offering. This report is an essential source for in-depth information and data relating to the Australia diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices in Australia Scope - The report provides diabetes care devices information broken down into detailed categories and segments in Australia. - Total revenues, products sold, end users, and average pricing. - Market shares of all the key competitors. - Key pipeline products that are set to shape the market, broken down by sector. - Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information. - Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement. - Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes. - Key mergers and acquisitions, partnerships, private equity investments and IPOs. - Customer, hospitals and physicians data. Reasons to buy - Gain a strong understanding of the diabetes care devices market in Australia. - Evaluate and compare the attractiveness of the market in the country. - Identify growth segments and opportunities in each industry sector within the country. - Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country. - Analyze the competitiveness of the market in the country and identify hotspots. - Develop strategies based on the latest product, brand, expansion and research and development news in the country. - Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country. - Identify and analyze the strengths and weaknesses of the industry incumbents in the country. Key Topics Covered: - Definitions of the Markets Covered in the Report - Healthcare Sector Review - Regulation System - Pricing and Reimbursement - Distribution Structure - Australia Medical Equipment Cross Market Comparison - Diabetes Care Devices In Australia - Glucose Monitoring In Australia - Insulin Delivery In Australia - F. Hoffmann-La Roche Ltd. Company Profile - Bayer HealthCare AG Company Profile - Novo Nordisk A/S Company Profile - LifeScan, Inc. Company Profile - Abbott Laboratories Company Profile - Eli Lilly and Company Company Profile - AiMedics Pty Ltd Company Profile - Roche Diagnostics Australia Pty. Ltd. Company Profile - List of Figures Companies Mentioned: - F. Hoffmann-La Roche Ltd. - Bayer HealthCare AG - Novo Nordisk A/S - LifeScan, Inc. - Abbott Laboratories - Eli Lilly and Company - AiMedics Pty Ltd - Roche Diagnostics Australia Pty. Ltd. For more information visit http://www.researchandmarkets.com/research/d20521/australia_diabetes Research and Markets Laura Wood Senior Manager press@researchandmarkets.com Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716 Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.


Follow Reuters